DrugDashboards

Oxybutynin Chloride Extended Release

Oxybutynin Chloride · OXYBUTYNIN CHLORIDE 10 mg/1 · Tablet, Extended Release · Oral · American Health Packaging

NDC 68084-0610-21 · 30 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. The price is down 9% over the past year, to $0.0978 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0978per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$12.73per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0978per TABweighted avg manufacturer price $0.0386 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Nov 2013Sep 2026$0.0978
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$2.94
#90 count
$8.81

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for oxybutynin chloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA078503
TE code
AB
Approval date
Feb 4, 2009
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Oxybutynin Chloride (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LimitedOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LimitedOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LimitedOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
AvPAKOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
AvPAKOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
AvPAKOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
direct rxOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Direct RxOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Oxybutynin Chloride Extended Release — NDC 68084-0610-21," retrieved September 3, 2026, https://drugdashboards.com/drug/68084061021.

Free to cite with attribution — see how the data is put together.